415 related articles for article (PubMed ID: 17696916)
1. The expression of CD23 in cutaneous non-lymphoid neoplasms.
Carvalho J; Fullen D; Lowe L; Su L; Ma L
J Cutan Pathol; 2007 Sep; 34(9):693-8. PubMed ID: 17696916
[TBL] [Abstract][Full Text] [Related]
2. Cluster designation 5 staining of normal and non-lymphoid neoplastic skin.
Bogner PN; Su LD; Fullen DR
J Cutan Pathol; 2005 Jan; 32(1):50-4. PubMed ID: 15660655
[TBL] [Abstract][Full Text] [Related]
3. Expression of Bcl-x in normal skin and benign cutaneous adnexal tumors.
Thamboo TP; Tan LH; Tan SY
J Cutan Pathol; 2006 Jan; 33(1):27-32. PubMed ID: 16441408
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous mixed tumor, eccrine variant: a clinicopathologic and immunohistochemical study of 50 cases, with emphasis on unusual histopathologic features.
Kazakov DV; Kacerovska D; Hantschke M; Zelger B; Kutzner H; Requena L; Grayson W; Bisceglia M; Schaller J; Kempf W; Denisjuk N; Michal M
Am J Dermatopathol; 2011 Aug; 33(6):557-68. PubMed ID: 21697702
[TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemical studies of normal sweat glands, sweat gland tumors and extramammary Paget's diseases. II. Immunohistochemical studies of sweat gland tumors and extramammary Paget's diseases].
Ansai S
Nihon Hifuka Gakkai Zasshi; 1990 Feb; 100(2):133-46. PubMed ID: 2165191
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
Wallace ML; Longacre TA; Smoller BR
Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
[TBL] [Abstract][Full Text] [Related]
7. SOX10 immunohistochemistry in sweat ductal/glandular neoplasms.
Cassarino DS; Su A; Robbins BA; Altree-Tacha D; Ra S
J Cutan Pathol; 2017 Jun; 44(6):544-547. PubMed ID: 28343365
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical detection of carcinoembryonic antigen and protein S-100 in sweat gland tumors].
Haneke E
Z Hautkr; 1986 Jan; 61(1-2):32-46. PubMed ID: 3513457
[TBL] [Abstract][Full Text] [Related]
9. Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation. Clinicopathologic and immunohistochemical study of eight cases.
Wong TY; Suster S; Cheek RF; Mihm MC
Am J Dermatopathol; 1996 Apr; 18(2):124-36. PubMed ID: 8739986
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of calretinin in normal skin and cutaneous adnexal proliferations.
González-Guerra E; Kutzner H; Rutten A; Requena L
Am J Dermatopathol; 2012 Jul; 34(5):491-505. PubMed ID: 22343111
[TBL] [Abstract][Full Text] [Related]
11. Calcification and ossification in eccrine mixed tumors: underrecognized feature and diagnostic pitfall.
Tirumalae R; Böer A
Am J Dermatopathol; 2009 Dec; 31(8):772-7. PubMed ID: 19730221
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of mucin core proteins and keratins in apocrine carcinoma, extramammary Paget's disease and apocrine nevus.
Miyamoto T; Inoue S; Adachi K; Takada R
J Cutan Pathol; 2009 May; 36(5):529-34. PubMed ID: 19476520
[TBL] [Abstract][Full Text] [Related]
13. Expression of stem-cell markers (cytokeratin 15 and nestin) in primary adnexal neoplasms-clues to etiopathogenesis.
Mahalingam M; Srivastava A; Hoang MP
Am J Dermatopathol; 2010 Dec; 32(8):774-9. PubMed ID: 20700038
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical differentiation of four benign eccrine tumors.
Missall TA; Burkemper NM; Jensen SL; Hurley MY
J Cutan Pathol; 2009 Feb; 36(2):190-6. PubMed ID: 18564284
[TBL] [Abstract][Full Text] [Related]
15. Her-2 expression in cutaneous eccrine and apocrine neoplasms.
Hiatt KM; Pillow JL; Smoller BR
Mod Pathol; 2004 Jan; 17(1):28-32. PubMed ID: 14631375
[TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation.
Ansai S; Koseki S; Hozumi Y; Kondo S
Am J Dermatopathol; 1995 Jun; 17(3):249-55. PubMed ID: 8599433
[TBL] [Abstract][Full Text] [Related]
17. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.
Sellheyer K; Nelson P; Kutzner H; Patel RM
J Cutan Pathol; 2013 Apr; 40(4):363-70. PubMed ID: 23398472
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous cribriform apocrine carcinoma: a clinicopathologic and immunohistochemical study of 26 cases of an under-recognized cutaneous adnexal neoplasm.
Rütten A; Kutzner H; Mentzel T; Hantschke M; Eckert F; Angulo J; Rodríguez Peralto JL; Requena L
J Am Acad Dermatol; 2009 Oct; 61(4):644-51. PubMed ID: 19751882
[TBL] [Abstract][Full Text] [Related]
19. Vulvar hidradenitis suppurativa. Immunohistochemical evaluation of apocrine and eccrine involvement.
Heller DS; Haefner HK; Hameed M; Lieberman RW
J Reprod Med; 2002 Sep; 47(9):695-700. PubMed ID: 12380447
[TBL] [Abstract][Full Text] [Related]
20. Staining of eccrine and apocrine neoplasms and metastatic adenocarcinoma with IKH-4, a monoclonal antibody specific for the eccrine gland.
Ishihara M; Mehregan DR; Hashimoto K; Yotsumoto S; Toi Y; Pietruk T; Mehregan AH; Mehregan DA
J Cutan Pathol; 1998 Feb; 25(2):100-5. PubMed ID: 9521499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
